LKT Labs, 714971-09-2

1 - 1 of 1
Sort
View
Show
  • LKT Labs

    BMS-599626 is a pan-HER inhibitor (including EGFR and VEGFR) that is currently in clinical trials as a potential treatment against several forms of cancer. BMS-599626 displays anticancer chemotherapeutic activity. In head and neck squamous cell carcinoma cells, BMS-599626 induces G1 phase cell…